Ache Laboratorios Farmaceuticos

Executive Summary

Aché Laboratórios Farmacêuticos is a leading Brazilian pharmaceutical company established in 1965, with a strong presence in therapeutic areas including cardiovascular, central nervous system, dermatology, gastroenterology, and respiratory. The company develops and commercializes both prescription and over-the-counter medicines, leveraging small molecule and biologic technologies. With a focus on the Brazilian and Latin American markets, Aché has built a reputation for addressing local healthcare needs through a diversified portfolio and a robust R&D pipeline. Its private status allows strategic flexibility in a competitive industry characterized by increasing demand for chronic disease treatments and aging populations.

Upcoming Catalysts (preview)

• Q4 2026Launch of a new cardiovascular biologic drug in Brazil60% success
• Q2 2027Strategic partnership for a CNS pipeline asset50% success
• H2 2026Expansion of OTC product line into Latin American markets70% success